River BioMedics

Recent Finacing

Seed

Recent Raise

$2.2M

River BioMedics develops hiPSC-derived 3D cardiac models and small-molecule therapeutics targeting genetically validated cardiac targets, using bioengineered 3D cardiac strips and mini-heart platforms for HFpEF and heart conditions.

Founded 2018

Overijssel, The Netherlands

1-10

Private

riverbiomedics.com

Highlights

Focus Areas

Biotechnology

Health Care

Hospital

Medical

Medical Device

Recent Investors

Financials

$2.2M

Total Raised

1

Funding round

4

Investors

Team

Upgrade to view the team

See the team members at River BioMedics.